English | دری

China fines British pharmaceutical firm for bribery

in International Business

GSKChina has fined the giant pharmaceutical firm of the UK, GlaxoSmithKline (GSK), USD 490mn for bribing doctors and hospitals in order to have their products promoted.

The court gave its sentence after a one-day trial at a court in Changsha, China.

GSK’s former head of Chinese operations, Mark Reilly, received a suspended three-year prison and he is set to be deported. Other GSK executives have also been given suspended jail sentences.

The scandal has become the biggest corruption scandal to hit a foreign firm in years, with the company being alleged for having made an estimated USD 150mn in illegal profits.

GSK has published a statement of apology to the Chinese government and its people.


Tags assigned to this article:
ChinaGlaxoSmithKline (GSK)GSK

Related Articles

Officials Consider Cull as Chinese Car Industry Reaching Crisis Point

The automobile industry was once hailed as one of China’s greatest success stories. In less than a decade, China became

China’s Manufacturing Sector Picking Up Pace

According to an HSBC survey, China’s Purchasing Manager’s Index (PMI) rose to 49.5 in July, a five-month high and up

China and Japan to start direct yen-yuan trade in June

China will allow direct trading of the yuan and the Japanese yen, in a move aimed at promoting trade between

No comments

Write a comment
No Comments Yet! You can be first to comment this post!

Write a Comment

Your e-mail address will not be published.
Required fields are marked*

Time limit is exhausted. Please reload the CAPTCHA.